BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 16777576)

  • 1. Ankylosing spondylitis and bowel disease.
    Rudwaleit M; Baeten D
    Best Pract Res Clin Rheumatol; 2006 Jun; 20(3):451-71. PubMed ID: 16777576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evolution of spondyloarthropathies in relation to gut histology. II. Histological aspects.
    Mielants H; Veys EM; Cuvelier C; De Vos M; Goemaere S; De Clercq L; Schatteman L; Elewaut D
    J Rheumatol; 1995 Dec; 22(12):2273-8. PubMed ID: 8835561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evolution of spondyloarthropathies in relation to gut histology. III. Relation between gut and joint.
    Mielants H; Veys EM; Cuvelier C; De Vos M; Goemaere S; De Clercq L; Schatteman L; Gyselbrecht L; Elewaut D
    J Rheumatol; 1995 Dec; 22(12):2279-84. PubMed ID: 8835562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evolution of spondyloarthropathies in relation to gut histology. I. Clinical aspects.
    Mielants H; Veys EM; De Vos M; Cuvelier C; Goemaere S; De Clercq L; Schatteman L; Elewaut D
    J Rheumatol; 1995 Dec; 22(12):2266-72. PubMed ID: 8835560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Joint involvement associated with inflammatory bowel disease.
    De Vos M
    Dig Dis; 2009; 27(4):511-5. PubMed ID: 19897967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review article: joint involvement in inflammatory bowel disease.
    De Vos M
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():36-42. PubMed ID: 15352892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerance of nonsteroidal antiinflammatory drugs in patients with inflammatory bowel disease.
    Bonner GF; Walczak M; Kitchen L; Bayona M
    Am J Gastroenterol; 2000 Aug; 95(8):1946-8. PubMed ID: 10950040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
    Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of nonsteroidal antiinflammatory drugs on inflammatory bowel disease: a case-control study.
    Felder JB; Korelitz BI; Rajapakse R; Schwarz S; Horatagis AP; Gleim G
    Am J Gastroenterol; 2000 Aug; 95(8):1949-54. PubMed ID: 10950041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of ankylosing spondylitis and Crohn's disease successfully treated with infliximab.
    Rebelo A; Leite S; Cotter J
    BioDrugs; 2010 Dec; 24 Suppl 1():37-9. PubMed ID: 21175236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory bowel disease.
    Moll JM
    Clin Rheum Dis; 1985 Apr; 11(1):87-111. PubMed ID: 2581732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inflammatory bowel disease and lung].
    Ceyhan B
    Tuberk Toraks; 2006; 54(3):292-8. PubMed ID: 17001550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory bowel disease. Current concepts of pathogenesis and implications for therapy.
    Fiocchi C
    Minerva Gastroenterol Dietol; 2002 Sep; 48(3):215-26. PubMed ID: 16491045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Crohn's disease following anti-tumour necrosis factor therapy (etanercept).
    Yazisiz V; Avci AB; Erbasan F; Yildirim B; Terzioğlu E
    Colorectal Dis; 2008 Nov; 10(9):953-4. PubMed ID: 18294265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Significance of intestinal inflammation in the pathogenesis of spondylarthropathies].
    Mielants H; Veys EM
    Verh K Acad Geneeskd Belg; 1996; 58(2):93-116. PubMed ID: 8768479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA-driven nutritional therapy of inflammatory bowel disease.
    Lee G; Buchman AL
    Nutrition; 2009 Sep; 25(9):885-91. PubMed ID: 19647622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A common genetic background for inflammatory bowel disease and ankylosing spondylitis: a genealogic study in Iceland.
    Thjodleifsson B; Geirsson AJ; Björnsson S; Bjarnason I
    Arthritis Rheum; 2007 Aug; 56(8):2633-9. PubMed ID: 17665420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histocompatibility antigens and other markers in ankylosing spondylitis and inflammatory bowel diseases.
    van dan Berg-Loonen PM; Dekker-Saeys AJ; Meuwissen SG; Nijenhuis LE
    J Rheumatol Suppl; 1977; 3():57-9. PubMed ID: 266599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ankylosing spondylitis, Reiter's syndrome, psoriatic arthritis, and arthritis of inflammatory bowel disease.
    Miller MM
    Prim Care; 1984 Jun; 11(2):271-82. PubMed ID: 6332327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arthritic manifestations of inflammatory bowel disease.
    Gravallese EM; Kantrowitz FG
    Am J Gastroenterol; 1988 Jul; 83(7):703-9. PubMed ID: 3289378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.